Global and China Veterinary-Animal Vaccines Dynamic Monitoring and Future Investment Report 2023
- Report Code : ARS2753482
- Published On: Jul, 2023
- Category : Healthcare & Pharma
- Pages : 100
-
The report aims at estimating the market size and future growth potential of Veterinary-Animal Vaccines market across different segments such as type, application and geography. The base year considered for the study is 2022, and the market size is forecast from 2023 to 2029.
The global Veterinary-Animal Vaccines market size in 2022 is 10690.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 6.90% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Veterinary-Animal Vaccines market include Bayer AG (Germany), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), and Merck & Co., Inc. (U.S.). The share of the top 3 players in the Veterinary-Animal Vaccines market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Veterinary-Animal Vaccines market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Porcine Vaccines accounted for XX% of Veterinary-Animal Vaccines market in 2022. Poultry Vaccines share of XX%.
Oral accounted for XX% of the Veterinary-Animal Vaccines market in 2022. Parenteral accounts for XX%.
The research methodology used to estimate and forecast the Veterinary-Animal Vaccines market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.
This report provides the integrated ecosystem of the Veterinary-Animal Vaccines market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.
Key Target audience:
Veterinary-Animal Vaccines Manufacturers and Suppliers
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Research Organizations
Academic Centers and Universities Associations and Industrial Bodies
Technology Investors
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Bayer AG (Germany)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Merck & Co., Inc. (U.S.)
Ceva (France)
Cargill, Incorporated (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Takeda Pharmaceutical Company Limited (Japan)
Zoetis (U.S.)
Dechra Pharmaceuticals PLC (U.K.)
Hester Biosciences Limited. (India)
Elanco (U.S.)
Phibro Animal Health Corporation (U.S.)
Indovax (India)
Types list
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
Bovine
Small Ruminant
Companion Animal Vaccines
Canine
Feline
Aquaculture Vaccines
Other Animal Vaccines
Application list
Oral
Parenteral
Topical
-
With tables and figures helping analyze worldwide Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Veterinary-Animal Vaccines Market Introduction and Overview1.1 Veterinary-Animal Vaccines Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Veterinary-Animal Vaccines Business Cost Analysis2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses2.2 Veterinary-Animal Vaccines Industrial Chain Analysis
3 Market Competition by Manufacturers3.1 Global Veterinary-Animal Vaccines Revenue and Market Share by Manufacturer
3.2 Manufacturers Veterinary-Animal Vaccines Production Sites, Area Served, Product Types
3.3 Veterinary-Animal Vaccines Market Competitive Situation and Trends
3.3.1 Veterinary-Animal Vaccines Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles4.1 Bayer AG (Germany)
4.1.1 Bayer AG (Germany) Company Profile
4.1.2 Veterinary-Animal Vaccines Product Overview
4.1.3 Bayer AG (Germany) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.1.4 Bayer AG (Germany) Business Overview4.2 Sanofi (France)
4.2.1 Sanofi (France) Company Profile
4.2.2 Veterinary-Animal Vaccines Product Overview
4.2.3 Sanofi (France) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.2.4 Sanofi (France) Business Overview4.3 Pfizer Inc. (U.S.)
4.3.1 Pfizer Inc. (U.S.) Company Profile
4.3.2 Veterinary-Animal Vaccines Product Overview
4.3.3 Pfizer Inc. (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.3.4 Pfizer Inc. (U.S.) Business Overview4.4 GSK plc (U.K.)
4.4.1 GSK plc (U.K.) Company Profile
4.4.2 Veterinary-Animal Vaccines Product Overview
4.4.3 GSK plc (U.K.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.4.4 GSK plc (U.K.) Business Overview4.5 Merck & Co., Inc. (U.S.)
4.5.1 Merck & Co., Inc. (U.S.) Company Profile
4.5.2 Veterinary-Animal Vaccines Product Overview
4.5.3 Merck & Co., Inc. (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.5.4 Merck & Co., Inc. (U.S.) Business Overview4.6 Ceva (France)
4.6.1 Ceva (France) Company Profile
4.6.2 Veterinary-Animal Vaccines Product Overview
4.6.3 Ceva (France) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.6.4 Ceva (France) Business Overview
4.7 Cargill, Incorporated (U.S.)
4.7.1 Cargill, Incorporated (U.S.) Company Profile
4.7.2 Veterinary-Animal Vaccines Product Overview
4.7.3 Cargill, Incorporated (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.7.4 Cargill, Incorporated (U.S.) Business Overview
4.8 Boehringer Ingelheim International GmbH. (Germany)
4.8.1 Boehringer Ingelheim International GmbH. (Germany) Company Profile
4.8.2 Veterinary-Animal Vaccines Product Overview
4.8.3 Boehringer Ingelheim International GmbH. (Germany) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.8.4 Boehringer Ingelheim International GmbH. (Germany) Business Overview
4.9 Takeda Pharmaceutical Company Limited (Japan)
4.9.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile
4.9.2 Veterinary-Animal Vaccines Product Overview
4.9.3 Takeda Pharmaceutical Company Limited (Japan) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.9.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview4.10 Zoetis (U.S.)
4.10.1 Zoetis (U.S.) Company Profile
4.10.2 Veterinary-Animal Vaccines Product Overview
4.10.3 Zoetis (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.10.4 Zoetis (U.S.) Business Overview
4.11 Dechra Pharmaceuticals PLC (U.K.)
4.11.1 Dechra Pharmaceuticals PLC (U.K.) Company Profile
4.11.2 Veterinary-Animal Vaccines Product Overview
4.11.3 Dechra Pharmaceuticals PLC (U.K.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.11.4 Dechra Pharmaceuticals PLC (U.K.) Business Overview
4.12 Hester Biosciences Limited. (India)
4.12.1 Hester Biosciences Limited. (India) Company Profile
4.12.2 Veterinary-Animal Vaccines Product Overview
4.12.3 Hester Biosciences Limited. (India) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.12.4 Hester Biosciences Limited. (India) Business Overview
4.13 Elanco (U.S.)
4.13.1 Elanco (U.S.) Company Profile
4.13.2 Veterinary-Animal Vaccines Product Overview
4.13.3 Elanco (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.13.4 Elanco (U.S.) Business Overview
4.14 Phibro Animal Health Corporation (U.S.)
4.14.1 Phibro Animal Health Corporation (U.S.) Company Profile
4.14.2 Veterinary-Animal Vaccines Product Overview
4.14.3 Phibro Animal Health Corporation (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.14.4 Phibro Animal Health Corporation (U.S.) Business Overview
4.15 Indovax (India)
4.15.1 Indovax (India) Company Profile
4.15.2 Veterinary-Animal Vaccines Product Overview
4.15.3 Indovax (India) Veterinary-Animal Vaccines Market Performance (2018-2023)
4.15.4 Indovax (India) Business Overview
5 Global Veterinary-Animal Vaccines Historical and Forecast Market Analysis by Type5.1 Market Size Analysis by Types
5.2 Global Veterinary-Animal Vaccines Revenue and Market Share by Type
5.3 Global Veterinary-Animal Vaccines Revenue Market Forecast by Type (2023-2029)
6 Global Veterinary-Animal Vaccines Historical and Forecast Market Analysis by Application6.1 Market Size Analysis by Application
6.2 Global Veterinary-Animal Vaccines Revenue Market Share by Application (2018-2023)
6.3 Veterinary-Animal Vaccines Revenue Market Forecast by Application (2023-2029)
7 Global Market Growth Trends Analysis7.1 Global Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
7.2 Veterinary-Animal Vaccines Growth Trends Analysis by Regions
7.2.1 Veterinary-Animal Vaccines Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Veterinary-Animal Vaccines Historic Revenue Market Size by Regions (2018-2023)
7.2.3 Veterinary-Animal Vaccines Forecasted Revenue Market Size by Regions (2023-2029)
7.2.4 North America Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
7.2.5 EMEA Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
7.2.6 China Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
7.2.7 Asia-Pacific (Excluding China) Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
7.2.8 Latin America Veterinary-Animal Vaccines Market Size & Forecast (2018-2029)
8 North America8.1 North America Veterinary-Animal Vaccines Revenue by Players
8.2 North America Veterinary-Animal Vaccines Revenue by Types
8.3 North America Veterinary-Animal Vaccines Revenue by Applications
8.4 North America Veterinary-Animal Vaccines Market by Countries
8.4.1 North America Veterinary-Animal Vaccines Revenue by Countries (2018-2029)8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China9.1 China Veterinary-Animal Vaccines Revenue by Players
9.2 China Veterinary-Animal Vaccines Revenue by Types
9.3 China Veterinary-Animal Vaccines Revenue by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)10.1 Asia Pacific Veterinary-Animal Vaccines Revenue by Players
10.2 Asia Pacific Veterinary-Animal Vaccines Revenue by Types
10.3 Asia Pacific Veterinary-Animal Vaccines Revenue by Applications
10.4 Asia Pacific Veterinary-Animal Vaccines Market by Countries
10.4.1 Asia Pacific Veterinary-Animal Vaccines Revenue by Countries (2018-2029)10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India10.10 Australia
11 EMEA11.1 EMEA Veterinary-Animal Vaccines Revenue by Players
11.2 EMEA Veterinary-Animal Vaccines Revenue by Types
11.3 EMEA Veterinary-Animal Vaccines Revenue by Applications
11.4 EMEA Veterinary-Animal Vaccines Market by Countries
11.4.1 EMEA Veterinary-Animal Vaccines Revenue by Countries (2018-2029)11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Veterinary-Animal Vaccines Revenue by Countries (2018-2029)
11.6.2 Germany
11.6.3 France
11.6.4 UK
11.6.5 Italy
11.6.6 Russia
11.6.7 Nordic
11.7 Middle East
11.8 Africa
12 Latin America12.1 Latin America Veterinary-Animal Vaccines Revenue by Players
12.2 Latin America Veterinary-Animal Vaccines Revenue by Types
12.3 Latin America Veterinary-Animal Vaccines Revenue by Applications
12.4 Latin America Veterinary-Animal Vaccines Market by Countries
12.4.1 Latin America Veterinary-Animal Vaccines Revenue by Countries (2018-2029)12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Veterinary-Animal Vaccines Industry Dynamic Analysis13.1 Veterinary-Animal Vaccines Market Trends Analysis
13.2 Veterinary-Animal Vaccines Market Drivers Analysis
13.3 Veterinary-Animal Vaccines Market Challenges Analysis
13.4 Veterinary-Animal Vaccines Market Restraints Analysis
14 Research Findings and Conclusion
-
The Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market has been segmented into
During the projected year from 2024 to 2029, the Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market is expected to grow at a CAGR of xx%.
The Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
The latest version of the Global and China Veterinary Animal Vaccines Dynamic Monitoring and Future Investment Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
